Agoracom: Small Cap Investment - Zenith Epigenetics - Re: One More Promissory Note-Aug 9/24

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

One More Promissory Note-Aug 9/24

KOO-KOO2

Aug 14, 2024 07:22AM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: One More Promissory Note-Aug 9/24

in response to

One More Promissory Note-Aug 9/24

KOO-KOO2

posted on Aug 14, 2024 10:21AM

Still no direct funding to Resverlogix.

Koo

1 Recommendations

Re: One More Promissory Note-Aug 9/24

fouremm

Aug 21, 2024 11:23AM

Re: One More Promissory Note-Aug 9/24

KOO-KOO2

Sep 08, 2024 07:41AM

Reply New Message

Back To Forum List View

Please to post a reply